Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0008 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |